Randomized controlled comparison of cosmetic outcomes of simple facial lacerations closed with Steri Strip Skin Closures or Dermabond tissue adhesive.
William T Zempsky, David Parrotti, Christine Grem...
https://pubmed.ncbi.nlm.nih.gov/15295247/Actively Recruiting
Led by Riverside University Health System Medical Center · Updated on 2026-07-07
610
Participants Needed
1
Research Sites
26 weeks
Total Duration
This research aims to evaluate whether using Steri-Strips, which are adhesive strips placed over surgical incisions, provides additional benefits after cesarean section C-section surgery. The study focuses on women undergoing C-sections and investigates if Steri-Strips reduce wound complications such as infections, fluid buildup under the skin, or reopening of the incision. Researchers also want to assess if Steri-Strips improve recovery, scar appearance, and cost-effectiveness compared to standard wound closure alone. Participants will be randomly assigned to one of two groups. One group will receive the usual cesarean skin closure followed by application of Steri-Strip adhesive strips according to a standardized protocol. The other group will receive the standard skin closure without Steri-Strips. The study will compare wound healing outcomes, complications, patient recovery, and costs between these two approaches. During the study, participants will be monitored for wound complications within 30 days after delivery. Researchers will track hospital stay length, readmissions related to wound issues, and the overall cost of wound care during this period. The study will last from cesarean delivery through 30 days postpartum, with participants involved in follow-up evaluations aimed at understanding the effects of Steri-Strips on healing and recovery.
CONDITIONS
Steri-Strip Application Versus Standard Wound Closure for Cesarean Section Incisions
M
Matthew Perera, DO, MS
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Riverside University Health System Medical Center
Lead Sponsor
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
| Factors | Steri-Strip™ + Standard Closure | Standard Closure Alone |
|---|---|---|
| What is it? | Standard cesarean wound closure followed by the application of Steri-Strip™ adhesive skin closures based on a standardized protocol. | Standard skin closure after cesarean section using institutional practices without additional Steri-Strip™ adhesive closures. |
| Role in study | Experimental arm evaluating if Steri-Strip™ closures reduce wound complications. | Active comparator reflecting standard closure approach. |
| Primary use | To provide additional wound support through adhesive strips after standard closure, potentially lowering risks of wound dehiscence, infection, or seroma. | To close skin incisions after cesarean delivery using institution’s established techniques, aiming for adequate wound healing without added adhesives. |
| How is it performed? | Skin is first closed by standard suture or staple method, then Steri-Strip™ adhesive strips are applied to the closed incision. | Skin incision is closed by standard institutional technique (suture or staples) without added adhesive strips. |
| Evidence status | Effectiveness for reducing cesarean wound complications is being studied. Prior published studies have shown Steri-Strip™ effectiveness in skin closure in other surgical or trauma wounds, but evidence specific to cesarean incisions is limited. | Standard closure is an established approach with long-standing use, but rates of wound complications such as infection or dehiscence remain and motivate alternative techniques. |
| Important risks | Patients with allergy to adhesive components may develop skin reactions such as contact dermatitis. Recent reports exist of rare allergic reactions to Steri-Strip™ products. | Usual surgical risks apply, such as infection, wound dehiscence, and seroma, but no specific allergy risk from closure material alone except possible suture or staple sensitivity. |
| Important limitations | Efficacy for reducing cesarean wound complications is not yet established in large clinical trials. Published data are limited mostly to wounds from other surgeries or trauma. Ongoing research aims to clarify benefits for cesarean incisions. | Though widely accepted, standard closure methods still carry risks of wound infection, dehiscence, and seroma, leading to efforts to explore adjunctive closure techniques. |
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - From delivery through 30 days postpartum
Participants undergo cesarean delivery with standard skin closure, with or without Steri-Strips applied according to group assignment.
Follow-up visits during the 30-day postpartum period
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Have more questions? Get in touch with our team for quick support
William T Zempsky, David Parrotti, Christine Grem...
https://pubmed.ncbi.nlm.nih.gov/15295247/Mattia Dominoni, Marco Torella, Rossella Molitierno...
https://pubmed.ncbi.nlm.nih.gov/40833607/Neha Sah, Rohit Punga, Ajay Kumar...
https://pubmed.ncbi.nlm.nih.gov/39234130/Anne Herman, Stefan Kerre, Ania Stras...
https://pubmed.ncbi.nlm.nih.gov/40114334/Jonathan D Hall, Elysa Schwartz
https://pubmed.ncbi.nlm.nih.gov/40821899/Riverside University Health System Medical Center
Lead Sponsor